Alvotech (NASDAQ:ALVOW – Get Free Report) shares were down 19.9% during trading on Wednesday . The stock traded as low as $0.2003 and last traded at $0.2003. Approximately 1,650 shares changed hands during trading, a decline of 66% from the average daily volume of 4,838 shares. The stock had previously closed at $0.25.
Alvotech Price Performance
The business’s 50-day moving average price is $0.25 and its two-hundred day moving average price is $0.39.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
- Five stocks we like better than Alvotech
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
